CORRECTION article

Front. Immunol., 24 January 2024

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1353835

Corrigendum: Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion

  • 1. Centre for Tumour Biology, Barts Cancer Institute, London, United Kingdom

  • 2. William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, John Vane Science Centre, Queen Mary University of London, London, United Kingdom

Article metrics

View details

1,3k

Views

726

Downloads

In the published article, there was an error in the Supplementary Material: Supplementary Methods, Page 7, at the sentence: “Identification was conducted using published criteria, briefly a minimum of six diagnostic ions in total ion count EPI spectrum, matching retention time to synthetic or authentic standards, MRM peaks with more than five data points, a signal-to-noise ratio > 3 (Supplementary Figure 2). [41]. The correct material statement appears below.

“Identification was conducted using published criteria, matching retention time to synthetic or authentic standards, MRM peaks with  more than five data points, a signal-to-noise ratio > 3 (UK/MAP). In a subset of samples the identity of these mediators was further confirmed by matching a minimum of six diagnostic ions in total ion count EPI spectrum to that of a reference standard (Supplementary Figure 2). [41]”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

pancreatic ductal adenocarcinoma, specialized pro-resolving mediator, lipid mediator, cancer-associated fibroblast, all-trans retinoic acid, ALOX15, CAF subtypes

Citation

Aguirre GA, Goulart MR, Bank BPT, Dalli J and Kocher HM (2024) Corrigendum: Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion. Front. Immunol. 15:1353835. doi: 10.3389/fimmu.2024.1353835

Received

11 December 2023

Accepted

16 January 2024

Published

24 January 2024

Volume

15 - 2024

Edited and reviewed by

Maarten Fokke Bijlsma, Academic Medical Center, Netherlands

Updates

Copyright

*Correspondence: Hemant M. Kocher, ; Jesmond Dalli,

†These authors have contributed equally to this work

‡ORCID: Gabriel A. Aguirre, orcid.org/0000-0003-4125-2661; Michelle R. Goulart, orcid.org/0000-0001-8333-3908; Jesmond Dalli, orcid.org/0000-0001-6328-3640; Hemant M. Kocher, orcid.org/0000-0001-6771-1905

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics